| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss and comprehensive loss | -3,496 | -8,651 | -6,589 | -5,452 |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -0.11 | -0.26 | -0.21 | -0.19 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.11 | -0.26 | -0.21 | -0.19 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 33,134,606 | 32,863,031 | 31,480,911 | 29,444,625 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 33,134,606 | 32,863,031 | 31,480,911 | 29,444,625 |
NeuroPace Inc (NPCE)
NeuroPace Inc (NPCE)